American medicine runs more than 14 billion tests a year. While some tests can be lifesaving, many are used at the wrong time or on the wrong patient and are useless or even harmful. The medical ...

Amprion, Inc., a global leader advancing diagnosis of neurodegenerative disorders through seed-amplification testing, has reached an agreement with Decathlon Capital Partners for a significant ...

It has been announced that two new rapid tests for the condition will be made available on the NHS.

Scientists from the University of Edinburgh say people with the condition have a distinct pattern of hormones.

The rise of automation and AI has raised fears about job loss, but smart tools can also train workers rather than replace ...

C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, announced that beginning October 1, 2026, eligible Anthem® Blue Cross® and Blue ...

What if a blood test could predict potential health problems rather than diagnose when the damage has been done? This is the ...

NeoGenomics, Inc.(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PTEN IHC CDx, the first immunohistochemistry (IHC) ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

A new diagnostic test system jointly developed at the University of Chicago Pritzker School of Molecular Engineering (PME) and UCLA Samueli School of Engineering fuses a powerful, sensitive transistor ...

Acquired immunodeficiency syndrome (AIDS) is caused by the human immunodeficiency virus (HIV) that attacks the body’s immune system, making it vulnerable to all infections. One of the major concerns ...